首页> 外文期刊>BJU international >Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
【24h】

Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.

机译:CDC91L1(PIG-U)在膀胱尿路上皮细胞癌中的过度表达:与临床变量和预后的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate cell division cycle 91-like 1 (CDC91L1; also called phosphatidylinositol glycan class U, PIG-U) expression in bladder cancer at both the mRNA and protein levels, and to study its clinical and prognostic significance, as CDC91L1 was recently identified as a new oncogene in human bladder cancer and its role in the biological behaviour of bladder cancer is largely unknown. PATIENTS AND METHODS: In all, 73 bladder tumours and 14 samples of normal bladder urothelium were studied by reverse-transcription polymerase chain reaction (PCR), real-time quantitative PCR and immunohistochemistry. RESULTS: The normalized CDC91L1 mRNA copy number in tumours was significantly greater than in normal controls (P < 0.05). There was overexpression of CDC91L1 mRNA in 30.1% (22/73) of the bladder tumours compared with the normal urothelium. At the protein level, 75.3% (55/73) of the bladder tumours and two of 14 of the normal urothelium had high expression of CDC91L1 protein, which is statistically significant (P < 0.001). The correlation between CDC91L1 protein and tumour grade, and muscle invasion of tumour was significant (both P < 0.05). In addition to tumour extent and tumour grade, CDC91L1 protein was an independent predictor of recurrence for superficial bladder cancer and had a trend to predict tumour progression. CONCLUSIONS: CDC91L1 (PIG-U) plays a role in the development of bladder urothelial cell carcinoma. CDC91L1 protein might be a potential biomarker for prediction of recurrence and a therapeutic target in bladder cancer.
机译:目的:研究mRNA和蛋白质水平在膀胱癌中的细胞分裂周期样91样1(CDC91L1;也称为磷脂酰肌醇聚糖U类,PIG-U)的表达,并研究其临床和预后意义。在人类膀胱癌中被鉴定为新的致癌基因及其在膀胱癌的生物学行为中的作用尚不清楚。患者与方法:通过逆转录聚合酶链反应(PCR),实时定量PCR和免疫组织化学研究了73例膀胱肿瘤和14例正常膀胱尿路上皮样品。结果:肿瘤中标准化的CDC91L1 mRNA拷贝数明显高于正常对照组(P <0.05)。与正常尿道上皮相比,CDC91L1 mRNA在30.1%(22/73)的膀胱肿瘤中过表达。在蛋白质水平上,75.3%(55/73)的膀胱肿瘤和14个正常尿路上皮中有2个CDC91L1蛋白高表达,具有统计学意义(P <0.001)。 CDC91L1蛋白与肿瘤的分级以及肿瘤的肌肉浸润之间存在显着相关性(均P <0.05)。除肿瘤程度和肿瘤等级外,CDC91L1蛋白是浅表性膀胱癌复发的独立预测因子,并具有预测肿瘤进展的趋势。结论:CDC91L1(PIG-U)在膀胱尿路上皮细胞癌的发展中起作用。 CDC91L1蛋白可能是预测膀胱癌复发和治疗靶点的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号